CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC - PubMed (original) (raw)
. 2012 Mar 23;419(4):612-6.
doi: 10.1016/j.bbrc.2012.02.050. Epub 2012 Feb 20.
Affiliations
- PMID: 22382030
- DOI: 10.1016/j.bbrc.2012.02.050
CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC
Ada Congrains et al. Biochem Biophys Res Commun. 2012.
Abstract
ANRIL is a newly discovered non-coding RNA lying on the strongest genetic susceptibility locus for cardiovascular disease (CVD) in the chromosome 9p21 region. Genome-wide association studies have been linking polymorphisms in this locus with CVD and several other major diseases such as diabetes and cancer. The role of this non-coding RNA in atherosclerosis progression is still poorly understood. In this study, we investigated the implication of ANRIL in the modulation of gene sets directly involved in atherosclerosis. We designed and tested siRNA sequences to selectively target two exons (exon 1 and exon 19) of the transcript and successfully knocked down expression of ANRIL in human aortic vascular smooth muscle cells (HuAoVSMC). We used a pathway-focused RT-PCR array to profile gene expression changes caused by ANRIL knock down. Notably, the genes affected by each of the siRNAs were different, suggesting that different splicing variants of ANRIL might have distinct roles in cell physiology. Our results suggest that ANRIL splicing variants play a role in coordinating tissue remodeling, by modulating the expression of genes involved in cell proliferation, apoptosis, extra-cellular matrix remodeling and inflammatory response to finally impact in the risk of cardiovascular disease and other pathologies.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
- Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A, Kamide K, Oguro R, Yasuda O, Miyata K, Yamamoto E, Kawai T, Kusunoki H, Yamamoto H, Takeya Y, Yamamoto K, Onishi M, Sugimoto K, Katsuya T, Awata N, Ikebe K, Gondo Y, Oike Y, Ohishi M, Rakugi H. Congrains A, et al. Atherosclerosis. 2012 Feb;220(2):449-55. doi: 10.1016/j.atherosclerosis.2011.11.017. Epub 2011 Nov 19. Atherosclerosis. 2012. PMID: 22178423 - Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, Sharpless NE. Burd CE, et al. PLoS Genet. 2010 Dec 2;6(12):e1001233. doi: 10.1371/journal.pgen.1001233. PLoS Genet. 2010. PMID: 21151960 Free PMC article. - Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Pasmant E, Sabbagh A, Masliah-Planchon J, Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K, Valeyrie-Allanore L, Parfait B, Vidaud D, Bièche I, Lantieri L, Wolkenstein P, Vidaud M; NF France Network. Pasmant E, et al. J Natl Cancer Inst. 2011 Nov 16;103(22):1713-22. doi: 10.1093/jnci/djr416. Epub 2011 Oct 27. J Natl Cancer Inst. 2011. PMID: 22034633 - ANRIL and atherosclerosis.
Chen L, Qu H, Guo M, Zhang Y, Cui Y, Yang Q, Bai R, Shi D. Chen L, et al. J Clin Pharm Ther. 2020 Apr;45(2):240-248. doi: 10.1111/jcpt.13060. Epub 2019 Nov 8. J Clin Pharm Ther. 2020. PMID: 31703157 Review. - Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.
Chi JS, Li JZ, Jia JJ, Zhang T, Liu XM, Yi L. Chi JS, et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):816-822. doi: 10.1007/s11596-017-1812-y. Epub 2017 Dec 21. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 29270737 Review.
Cited by
- Role of lncRNAs in aging and age-related diseases.
He J, Tu C, Liu Y. He J, et al. Aging Med (Milton). 2018 Jul 30;1(2):158-175. doi: 10.1002/agm2.12030. eCollection 2018 Sep. Aging Med (Milton). 2018. PMID: 31942494 Free PMC article. Review. - LncRNAs in vascular biology and disease.
Simion V, Haemmig S, Feinberg MW. Simion V, et al. Vascul Pharmacol. 2019 Mar;114:145-156. doi: 10.1016/j.vph.2018.01.003. Epub 2018 Feb 6. Vascul Pharmacol. 2019. PMID: 29425892 Free PMC article. Review. - Mining the Stiffness-Sensitive Transcriptome in Human Vascular Smooth Muscle Cells Identifies Long Noncoding RNA Stiffness Regulators.
Yu CK, Xu T, Assoian RK, Rader DJ. Yu CK, et al. Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):164-173. doi: 10.1161/ATVBAHA.117.310237. Epub 2017 Oct 19. Arterioscler Thromb Vasc Biol. 2018. PMID: 29051139 Free PMC article. - MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
Jakubik D, Fitas A, Eyileten C, Jarosz-Popek J, Nowak A, Czajka P, Wicik Z, Sourij H, Siller-Matula JM, De Rosa S, Postula M. Jakubik D, et al. Cardiovasc Diabetol. 2021 Feb 27;20(1):55. doi: 10.1186/s12933-021-01245-2. Cardiovasc Diabetol. 2021. PMID: 33639953 Free PMC article. Review. - Molecular Genetics and Functional Analysis Implicate CDKN2BAS1-CDKN2B Involvement in POAG Pathogenesis.
Rathi S, Danford I, Gudiseva HV, Verkuil L, Pistilli M, Vishwakarma S, Kaur I, Dave T, O'Brien JM, Chavali VRM. Rathi S, et al. Cells. 2020 Aug 21;9(9):1934. doi: 10.3390/cells9091934. Cells. 2020. PMID: 32825664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical